Ban-Feng Ruan

Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors

Using a fragment-based drug design strategy, two biomedical interesting fragments, resveratrol and coumarin were linked to design a series of novel human monoamine oxidase (hMAO) inhibitors with a scaffold of 3-((E)-3-(2-((E)-styryl)phenyl)acryloyl)-2H-chromen-2-one, which demonstrated a very interesting selectivity profile against hMAO-A and hMAO-B: some compounds with this scaffold are selective hMAO-A inhibitors, whereas some are selective hMAO-B inhibitors. The small changes in the substituents of the coumarin moiety led to this interesting selectivity profile. The most potent selective hMAO-B inhibitor D7 has a selectivity ratio of 20.93, with an IC₅₀ value of 2.78 μM, similar or better than selegiline (IC₅₀ = 2.89 μM), a selective hMAO-B inhibitor currently in the market for the treatment of Parkinsons disease. Our modeling study indicates that Tyr 326 of hMAO-B (or corresponded Ile 335 of hMAO-A) may be the determinant for the specificity of these compounds. The selectivity profile of compounds reported herein suggests that we can further develop both selective hMAO-A and hMAO-B inhibitors based on this novel scaffold.

Synthesis, characterization, and antitumor activities of two copper(II) complexes with pyrazole derivatives

Two mononuclear copper(II) complexes with pyrazole derivatives, 1,1′-(anthracen-9-ylmethylene)bis(1H-pyrazole) (L1 ) and 9-(4-(di(1H-pyrazol-1-yl)methyl)phenyl)-9H-carbazole (L2 ), of formulae [CuL1(CH3CN)2](ClO4)2 (1) and [CuL2(CH3CN)2](ClO4)2 (2) were prepared. Both complexes were confirmed by IR, MS, 1H NMR, and elemental analyses. Complex 1 was also characterized by X-ray crystallography, confirming that copper(II) is coordinated by four nitrogen atoms from two L1 and two oxygen atoms from two perchlorates. Furthermore, all ligands and complexes were tested in vitro for their antitumor activities using mouse melanoma cell line B16-F10, HepG2 human hepatoma cell line, and A549 human lung adenocarcinoma cell line. Both complexes displayed potent cytotoxicity and are promising substrates for further investigations.

Synthesis, crystal structure and in vitro antitumor activity of a novel organotin(IV) complex with 9-hexyl-9H-carbazole-3-carboxylic acid

Abstract9-Hexyl-9H-carbazole-3-carboxylic acid (LCOOH) and its complex with Ph3Sn(OH), [Ph3SnO2CL] (I), were synthesized. The structure of complex I was solved by single-crystal X-ray diffraction determination, indicating that I shows the discrete framework. Furthermore, this complex was tested in vitro for its cytotoxic activity, using human hepatocellular carcinoma cell line (BEL-7402) and human hepatocellular liver carcinoma cell line (HepG2); 5-fluorouracil was used as a positive control substance. This complex showed cytotoxicity greater than that of 5-fluorouracil.

Microwave solid phase synthesis, characterization, and antimicrobial activity of 3,5-diiodo-salicylalidene-glycine-cobalt(II)

One mononuclear complex, C9H7I2NO4Co(II) (I) with 3,5-diiodo-salicylalidene, glycine and Co(CH3COO)2 · 4H2O were microwave solid synthesized. The complex was characterized by X-ray crystallography, UV, IR, ESI-MS, and elemental analyses. In addition, further investigation revealed that the central cobalt(II) atom in complex is five-coordinated by one nitrogen atom and four oxygen atoms. The complex was assayed for antibacterial (B. subtilis, S. aureus, S. faecalis, P. aeruginosa, E. coli, and E. cloacae) activities by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl trtrazolium bromide) method. Complex I showed favorable antimicrobial activity with MICs of 3.125, 6.25, 6.25, 6.25, 3.125, and 6.25 μg/mL against B. subtilis, S. aureus, S. faecalis, P. aeruginosa, E. coli, and E. cloacae, respectively.

Synthesis, crystal structure, and in vitro antitumor activity of a novel tetranuclear Di-n-butyltin(IV)

A di-n-butyltin(IV) complex with (E)-3-(4-(9H-carbazole-9-yl)phenyl) acrylic acid (HL) of the formula {[n-Bu2SnOL]2O}2 was synthesized and characterized by X-ray crystallography. This complex is a tetranuclear one with ladder framework. Furthermore, this complex was tested in vitro for its cytotoxic activity, using human hepatocellular carcinoma cell line (BEL-7402) and human hepatocellular liver carcinoma cell line (HepG2); 5-Fluorouracil was used as a positive control substance. This complex showed cytotoxicity greater than that of 5-Fluorouracil.